Alexandru Calin Grigorescu 2025. Tirosine Kinase Inhibitors (TKI) Used in the Treatment of Non-Small Cell Lung Cancer (NSCLC) Based on Specific Genetic Alterations. Medical Science: Trends and Innovations Vol. 4. (Feb. 2025), 86–93. DOI:https://doi.org/10.9734/bpi/msti/v4/4098.